A quantitative PCR assay for SV40 neutralization adaptable for high-throughput applications

Journal of Virological Methods

Volumn 162, Issue 1-2, 2009, Pages 236-244

  Murata, Haruhiko ^a   Teferedegne, Belete ^a   Lewis Jr , Andrew M ^a   Peden, Keith ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Antibody; Neutralization; Polyomavirus; Quantitative PCR; SV40; SYBR Green

Indexed keywords

NEUTRALIZING ANTIBODY; NUCLEIC ACID;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; DILUTION; EXTRACTION; GENE AMPLIFICATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TEMPERATURE; VIRUS GENOME; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DNA PRIMERS; DNA, VIRAL; KIDNEY; NEUTRALIZATION TESTS; ORGANIC CHEMICALS; POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TEMPLATES, GENETIC; VIRUS REPLICATION;

BK POLYOMAVIRUS; POLYOMAVIRUS;

EID: 70349731910     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.08.012     Document Type: Article

References (34)

1. Allander T., Andreasson K., Gupta S., Bjerkner A., Bogdanovic G., Persson M.A., Dalianis T., Ramqvist T., and Andersson B. Identification of a third human polyomavirus. J. Virol. 81 (2007) 4130-4136
2. Babé L.M., Brew K., Matsuura S.E., and Scott W.A. Epitopes on the major capsid protein of simian virus 40. J. Biol. Chem. 264 (1989) 2665-2671
3. Berger J.R. Progressive multifocal leukoencephalopathy. Curr. Neurol. Neurosci. Rep. 7 (2007) 461-469
4. Brade L., Muller-Lantzsch N., and zur Hausen H. B-Lymphotropic papovavirus and possibility of infections in humans. J. Med. Virol. 6 (1980) 301-308
5. Buck C.B., Pastrana D.V., Lowy D.R., and Schiller J.T. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol. Med. 119 (2005) 445-462
6. Carter J.J., Madeleine M.M., Wipf G.C., Garcea R.L., Pipkin P.A., Minor P.D., and Galloway D.A. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J. Natl. Cancer Inst. 95 (2003) 1522-1530
7. Delbue S., Tremolada S., Branchetti E., Elia F., Gualco E., Marchioni E., Maserati R., and Ferrante P. First identification and molecular characterization of lymphotropic polyomavirus in peripheral blood from patients with leukoencephalopathies. J. Clin. Microbiol. 46 (2008) 2461-2462
8. Dropulic L.K., and Jones R.J. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 41 (2008) 11-18
9. Feng H., Shuda M., Chang Y., and Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 (2008) 1096-1100
10. Flaegstad T., and Traavik T. Detection of BK virus antibodies measured by enzyme-linked immunosorbent assay (ELISA) and two haemagglutination inhibition methods: a comparative study. J. Med. Virol. 16 (1985) 351-356
11. Flaegstad T., Traavik T., Christie K.E., and Joergensen J. Neutralization test for BK virus: plaque reduction detected by immunoperoxidase staining. J. Med. Virol. 19 (1986) 287-296
12. Gaynor A.M., Nissen M.D., Whiley D.M., Mackay I.M., Lambert S.B., Wu G., Brennan D.C., Storch G.A., Sloots T.P., and Wang D. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog. 3 (2007) e64
13. Hamilton R.S., Gravell M., and Major E.O. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J. Clin. Microbiol. 38 (2000) 105-109
14. Hirsch H.H., Brennan D.C., Drachenberg C.B., Ginevri F., Gordon J., Limaye A.P., Mihatsch M.J., Nickeleit V., Ramos E., Randhawa P., Shapiro R., Steiger J., Suthanthiran M., and Trofe J. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79 (2005) 1277-1286
15. Kean J.M., Rao S., Wang M., and Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog. 5 (2009) e1000363
16. Kreader C.A. Relief of amplification inhibition in PCR with bovine serum albumin or T4 gene 32 protein. Appl. Environ. Microbiol. 62 (1996) 1102-1106
17. McNees A.L., White Z.S., Zanwar P., Vilchez R.A., and Butel J.S. Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J. Clin. Virol. 34 (2005) 52-62
18. Minor P., Pipkin P., Jarzebek Z., and Knowles W. Studies of neutralising antibodies to SV40 in human sera. J. Med. Virol. 70 (2003) 490-495
19. Murata H., Peden K., and Lewis Jr. A.M. Identification of a mutation in the SV40 capsid protein VP1 that influences plaque morphology, vacuolization, and receptor usage. Virology 370 (2008) 343-351
20. Murata H., Teferedegne B., Sheng L., Lewis Jr. A.M., and Peden K. Identification of a neutralization epitope in the VP1 capsid protein of SV40. Virology 381 (2008) 116-122
21. Ozer H.L., and Takemoto K.K. Site of host restriction of simian virus 40 mutants in an established African green monkey kidney cell line. J. Virol. 4 (1969) 408-415
22. Pal A., Sirota L., Maudru T., Peden K., and Lewis Jr. A.M. Real-time, quantitative PCR assays for the detection of virus-specific DNA in samples with mixed populations of polyomaviruses. J. Virol. Methods 135 (2006) 32-42
23. Pastrana D.V., Buck C.B., Pang Y.Y., Thompson C.D., Castle P.E., FitzGerald P.C., Kruger Kjaer S., Lowy D.R., and Schiller J.T. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321 (2004) 205-216
24. Peden K.W.C., Pipas J.M., Pearson-White S., and Nathans D. Isolation of mutants of an animal virus in bacteria. Science 209 (1980) 1392-1396
25. Poulin D.L., and DeCaprio J.A. Is there a role for SV40 in human cancer?. J. Clin. Oncol. 24 (2006) 4356-4365
26. Rinaldo C.H., and Hirsch H.H. Antivirals for the treatment of polyomavirus BK replication. Expert Rev. Anti Infect. Ther. 5 (2007) 105-115
27. Saito T., Munakata Y., Fu Y., Fujii H., Kodera T., Miyagawa E., Ishii K., and Sasaki T. Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction. J. Virol. Methods 107 (2003) 81-87
28. Sauerbrei A., and Wutzler P. Testing thermal resistance of viruses. Arch. Virol. 154 (2009) 115-119
29. Shuda M., Feng H., Kwun H.J., Rosen S.T., Gjoerup O., Moore P.S., and Chang Y. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 16272-16277
30. In: Stratton K., Alamario D.A., and McCormick M.C. (Eds). Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer (2003), The National Academies Press, Washington, DC
31. van Santen V.L., Kaltenboeck B., Joiner K.S., Macklin K.S., and Norton R.A. Real-time quantitative PCR-based serum neutralization test for detection and titration of neutralizing antibodies to chicken anemia virus. J. Virol. Methods 115 (2004) 123-135
32. Viscidi R.P., and Clayman B. Serological cross reactivity between polyomavirus capsids. Adv. Exp. Med. Biol. 577 (2006) 73-84
33. Wong S., and Brown K.E. Development of an improved method of detection of infectious parvovirus B19. J. Clin. Virol. 35 (2006) 407-413
34. Yuan L., Zhang X., Chang M., Jia C., Hemmingsen S.M., and Dai H. A new fluorescent quantitative PCR-based in vitro neutralization assay for white spot syndrome virus. J. Virol. Methods 146 (2007) 96-103